Impact of BRCA1/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample
Journal of Clinical OncologyPublished 15 January 2002
M. D. Schwartz
Citations218
SJR quartileQ1
SJR score11.21
SNIP5.98
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is suggested that clinic-based BRCA1/2 testing can lead to psychologic benefits for individuals who receive negative test results, and at 6 months after disclosure, those who receive positive or uninformative test results do not exhibit increased psychologic distress or perceived risk.
Abstract
These results suggest that clinic-based BRCA1/2 testing can lead to psychologic benefits for individuals who receive negative test results. At 6 months after disclosure, those who receive positive or uninformative test results do not exhibit increased psychologic distress or perceived risk.
Keywords
Social SciencesMedicineBiochemistry, Genetics and Molecular Biology
Psychosomatic MedicineImpact of Event Scale: A Measure of Subjective Stress
7,877 Citations1979Mardi J. Horowitz, Nancy Wilner +1 more
A scale of current subjective distress, related to a specific event, was based on a list of items composed of commonly reported experiences of intrusion and avoidance, and responses indicated that the scale had a useful degree of significance and homogeneity.
The American Journal of Human GeneticsGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
3,047 Citations1998Deborah Ford, Douglas F. Easton +36 more
The lifetime risk of breast cancer appears similar to the risk in BRCA1 carriers, but there was some suggestion of a lower risk in bRCA2 carriers <50 years of age.
New England Journal of MedicineThe Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews
2,262 Citations1997Jeffery P. Struewing, Patricia Hartge +7 more
The risks of breast cancer may be overestimated, but they fall well below previous estimates based on subjects from high-risk families.
The LancetRisks of cancer in BRCA1-mutation carriers
1,866 Citations1994Daniel Ford
Estimates of breast and ovarian cancer risks are provided which are useful for counselling BRCA1-mutation carriers and carriers are at increased risk of colon and prostate cancer, which may be of clinical significance in certain families if the risks are associated with specific mutations.
PubMedBreast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
1,587 Citations1995Douglas F. Easton, Deborah Ford +1 more
Data from families with evidence of linkage to BRCA1 is used to estimate the age-specific risks of breast and ovarian cancer in BRCa1-mutation carriers and to examine the variation in risk between and within families.
JNCI Journal of the National Cancer InstituteCancer Risks in BRCA2 Mutation Carriers
1,527 Citations1999The Breast Cancer Linkage Consortium
In addition to the large risks of breast and ovarian cancers, BRCA2 mutations may be associated with increased risks of several other cancers.
New England Journal of MedicineEfficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
1,413 Citations1999Lynn C. Hartmann, Daniel J. Schaid +12 more
In women with a high risk of breast cancer on the basis of family history, prophylactic mastectomy can significantly reduce the incidence of Breast cancer.
New England Journal of Medicine<i>BRCA1</i>Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
681 Citations1997Fergus J. Couch, Michelle L. DeShano +11 more
The results suggest that even in a referral clinic specializing in screening women from high-risk families, the majority of tests for BRCA1 mutations will be negative and therefore uninformative.
JNCI Journal of the National Cancer InstituteBreast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
678 Citations1999Timothy R. Rebbeck, Albert M. Levin +13 more
Bilateral prophylactic oophorectomy is associated with a reduced breast cancer risk in women who carry a BRCA1 mutation, and the likely mechanism is reduction of ovarian hormone exposure.
American Journal of Medical GeneticsUnusual case of Smith‐Lemli‐Opitz syndrome “type II”
588 Citations1995Mary J. Seller, J. A. Russell +1 more
The findings in this fetus extend the wide spectrum of abnormalities of the SLO phenotype, and emphasize that a genetic pathological examination and biochemical studies should always be undertaken on atypical cases, especially fetuses.
PubMedExternal validating criteria for psychiatric diagnosis: their application in affective disorders.
477 Citations1980Peter Hesbacher
Journal of Clinical OncologySequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
462 Citations1998T. Frank, Susan Manley +23 more
Analysis of these genes should be considered for women diagnosed with breast cancer who have a high probability of carrying a mutation according to the statistical model developed with these data.
JAMALong-term Satisfaction and Psychological and Social Function Following Bilateral Prophylactic Mastectomy
325 Citations2000Marlene H. Frost
This study suggests that positive outcomes following prophylactic mastectomy include decreased emotional concern about developing breast cancer and generally favorable psychological and social outcomes.
JAMAGenetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer
294 Citations1993Barbara B. Biesecker
This work has identified several families that show linkage between breast and/or ovarian cancer and genetic markers that flank BRCA1 and developed a protocol to address the many issues that arise in the delivery of these services.
Health PsychologyPsychological responses to BRCA1 mutation testing: Preliminary findings.
290 Citations1997Robert T. Croyle, Ken R. Smith +3 more
Although general distress (state anxiety) declined after testing, carriers were more distressed than noncarriers at follow-up, andGene mutation carriers manifested significantly higher levels of test-related psychological distress, as measured by the Impact of Event Scale, when compared with noncarrier.
Preventive MedicineProphylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 Testing
247 Citations2000Caryn Lerman, Chanita Hughes +8 more
The vast majority of BRCA1/2 carriers may not opt for prophylactic surgery, and many do not adhere to surveillance recommendations, suggesting greater attention to risk communication and medical decision-making is warranted.
BMJThe psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured
158 Citations2001M.Bebbington Hatcher
Bilateral prophylactic mastectomy may provide psychological benefits in women with a high risk of developing breast cancer and to identify, preoperatively, risk factors for postoperative distress.
The American Journal of Human GeneticsScreening for Genomic Rearrangements in Families with Breast and Ovarian Cancer Identifies BRCA1 Mutations Previously Missed by Conformation-Sensitive Gel Electrophoresis or Sequencing
158 Citations2000Meredith A. Unger, Katherine L. Nathanson +7 more
The prior probability of detecting a BRCA1 mutation may be a useful predictor when considering the use of Southern blot analysis for families with breast/ovarian cancer who do not have detectable coding-region mutations.
Journal of Clinical OncologyAnticipated Versus Actual Emotional Reactions to Disclosure of Results of Genetic Tests for Cancer Susceptibility: Findings From p53 and BRCA1 Testing Programs
144 Citations2000Michel Dorval, Andrea Farkas Patenaude +10 more
Unaffected individuals in cancer-predisposition testing programs are generally accurate in anticipating emotional reactions to test results, however, cancer patients may underestimate their distress after disclosure of positive results and could benefit from intervention strategies.
Annals of Behavioral MedicinePsychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal
134 Citations1997Janet Audrain, Mark D. Schwartz +4 more
The findings suggest that self-referred genetic counseling participants may be psychologically vulnerable and may benefit from interventions designed to decrease distress and the perceived absence of control over developing breast cancer.
Journal of Consulting and Clinical PsychologyDistress and psychiatric morbidity among women from high-risk breast and ovarian cancer families.
131 Citations2000James C. Coyne, Nili R. Benazon +3 more
Low level of psychological distress and the prevalence of psychiatric disorder were low and in the range that would be expected for a sample of community-residing women, and screening proved inefficient.
PubMedSpiritual faith and genetic testing decisions among high-risk breast cancer probands.
106 Citations2000Marc D. Schwartz, Chanita Hughes +6 more
The role that spirituality may play in the decision-making process about genetic testing is highlighted, as women who perceived themselves to be at low risk of developing breast cancer again were significantly less likely to be tested, compared with those with lower levels of faith.
Annals of Surgical OncologyWomen?s Regrets After Bilateral Prophylactic Mastectomy
103 Citations2000David Payne, Carina Biggs +3 more
Although a PM statistically reduces the chances of a woman developing breast cancer, the possibility of significant physical and psychological sequelae remains and careful evaluation, education, and support both before and after the procedure will potentially reduce the level of distress and dissatisfaction.